Antibody-Mediated Blockade of the IL23 Receptor Destabilizes Intratumoral Regulatory T Cells and Enhances Immunotherapy

By
Danielle Corrigan
-
0
170
Researchers provided evidence that the interleukin 23 (IL23) receptor expressed by tumor-infiltrating regulatory T cells promoted suppressive activity.
[Proceedings of the National Academy of Sciences of the United States of America]
Abstract